While the headlines focus on weight loss, the science behind GLP-1 medications runs much deeper. Originally designed for metabolic health, these molecules do far more than just quiet "food noise" or drop pounds. They are powerful systemic tools that significantly lower chronic inflammation, protect our cardiovascular health (reducing heart attacks and strokes), and protect kidney and liver function.  

For many, they also dramatically improve sleep quality by addressing obstructive sleep apnea. In my clinical experience, some patients report benefits at lower doses, often with fewer side effects. Research on microdosing is still developing.

Micro-dosing these medications has been linked to reduced levels of pro-inflammatory cytokines like IL-6 and TNF-α, which play roles in autoimmune diseases, cardiovascular risk, and aging-related decline. 

Many patients must discontinue GLP-1 medications due to cost or side effects like nausea and fatigue. Micro-dosing offers a solution by reducing these issues while still delivering meaningful benefits.  

It’s also a promising option for individuals who don’t need to lose weight but want to improve insulin sensitivity, stabilize energy levels, or reduce inflammation. 

Because everyone's biology is different, high standard doses aren't always necessary to see these profound metabolic changes. My practice focuses on a personalized, conservative approach to health. If you are interested in exploring a lower-dose, metabolic-first protocol tailored to your unique biology, please contact our office to schedule a consultation.